Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. It is advancing two parallel lead product candidates, ELVN-001 and ELVN-002, and pursuing several additional research stage opportunities that align with its development approach. Its first product candidate, ELVN-001, is a potent, highly selective, small molecule kinase inhibitor designed to specifically target the breakpoint cluster region-Abelson (BCR-ABL) gene fusion, the oncogenic driver for patients with chronic myeloid leukemia (CML). ELVN-001 is an adenosine triphosphate (ATP)-competitive tyrosine kinase inhibitor (TKI). The Company's second product candidate, ELVN-002, is a potent, highly selective, central nervous system penetrant and irreversible human epidermal growth factor receptor 2 (HER2) inhibitor with activity against wild type HER2 and various HER2 mutations.
Find out what a historical investment in Enliven Therapeutics Inc would be worth today using our ELVN stock calculator.
Buying ELVN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Enliven Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in ELVN
What is the ticker symbol of Enliven Therapeutics Inc?
The ticker symbol for Enliven Therapeutics Inc is ELVN.
How much is one share of ELVN?
One share of ELVN is valued at $46.41 as of 20 November 2026.
What is the market capitalisation of Enliven Therapeutics Inc ELVN?
As of 20 November 2026 Enliven Therapeutics Inc has a market cap of $3.30B.
What is the 52-week high for Enliven Therapeutics Inc stock?
The Enliven Therapeutics Inc 52-week high stock price is $62.32.
What is the 52-week low for Enliven Therapeutics Inc stock?
The Enliven Therapeutics Inc 52-week low stock price is $14.79.
Can I buy ELVN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ELVN shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ELVN on Stake
Buy ELVN from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of ELVN from only US$10 with fractional shares